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Human Endometrial Stromal Stem Cells Differentiate
into Megakaryocytes with the Ability to Produce
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Ying Zhang3, Wenfeng Zhang1, Lawrence Amesse2", Yanfang Chen1*"
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Abstract
Human endometrium is a high dynamic tissue that contains endometrial stromal stem cells (hESSCs). The hESSCs have been
differentiated into a number of cell lineages. However, differentiation of hESSCs into megakaryocytes (MKs) has not yet
been investigated. The aim of this study was to investigate the feasibility of MK generation from hESSCs and subsequent
production of functional platelets (PLTs). In our study, hESSCs were cultured from endometrial stromal cells as confirmed by
positive stromal cell specific markers (CD90 and CD29) and negative hematopoietic stem cell markers (CD45 and CD34)
expression. Then, hESSCs were differentiated in a medium supplemented with thrombopoietin (TPO) for 18 days. The MK
differentiation was analyzed by flow cytometry and confocal microscopy. The differentiation medium was collected for PLT
production analysis by flow cytometry, transmission electron microscopy and functional measurements. Our results show: 1)
MKs were successfully generated from hESSCs as identified by expression of specific markers (CD41a: 160.09% and
3963.0%; CD42b: 1.260.06% and 2862.0%, control vs. differentiation) accompanied with reduction of pluripotent
transcription factors (Oct4 and Sox2) expression; 2) The level of PLTs in the differentiation medium was 1661 number/ml as
determined by size (2–4 mm) and CD41a expression (CD41a: 160.4% and 9062.0%, control vs. differentiation); 3) Generated
PLTs were functional as evidenced by the up-regulation of CD62p expression and fibrinogen binding following thrombin
stimulation; 4) Released PLTs showed similar ultra-structure characteristics (alpha granules, vacuoles and dense tubular
system) as PLTs from peripheral blood determined by electron microscopic analysis. Data demonstrate the feasibility of
generating MKs from hESSCs, and that the generated MKs release functional PLTs. Therefore, hESSCs could be a potential
new stem cell source for in vitro MK/PLT production.
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cells [9–12] and hematopoietic stem cells (HSCs) harvested from
bone marrow, peripheral blood and cord blood [13–15] have been
explored for MK production. However, there are several wellestablished limitations of these sources, including achieving
adequate amounts of HSCs and flawed maturation, as well as
political and ethical ramifications.
The endometrium of reproductive-age women is highly
dynamic with its remarkable capacity for self-renewal attributed
to stromal progenitor or stem cells [16]. Human endometrial
stromal stem cells (hESSCs) can be isolated relatively simply from
endometrium and maintained in cell culture. The cells can be
cultured for more than 15 passages (.20 months) [17]. In
addition, successful differentiation of hESSCs into targeted cells
has clinical significance because it can provide an autologous cell
source that avoids the complications associated with allogeneic
transplantation. Indeed, these characteristics render hESSCs a

Introduction
Platelets (PLTs) play a key role in haemostatic plug formation
[1] and arterial thrombosis [2]. PLT transfusion is a mainstay
therapy of various PLT-related diseases, such as thrombocytopenia and in cases of menorrhagia that are refractory to medical
therapy [3–6]. In the United States, the total number of PLT
transfusions is over 10 million units per year and is increasing
annually. Traditional source of PLTs from blood donors has
several limitations, including short storage life of PLT concentrates
and risk of pathogenic contamination [7,8]. Thus, developing a
reliable, safe alternative approach to producing large numbers of
PLTs is intensely appealing.
Stem cell based generation of megakaryocytes (MKs), the parent
cells of circulating PLTs, would provide significant advantages
over the current donor-supply approach. So far, embryonic stem
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potentially good cell source for regenerative medicine. So far,
hESSCs have been reported to be capable of differentiating into
mesodermal and ectodermal lineages, including smooth muscle
cells [18], adipocytes [17,18], chondrocytes [18,19], osteoblasts
[18], pancreatic b-cells [20] and neurons [21]. However, to our
knowledge, there is no report of differentiating hESSCs into MKs.
In this study, we investigated whether hESSCs could be
differentiated into MKs and the generated MKs could release
functional PLTs in an in vitro culture system.

Characterization of hESSCs
The passage 4 and 6 (P4, 6) cultured cells were characterized by
flow cytometry and immunocytochemistry methods. Flow cytometric results showed that the hESSCs positively expressed
stromal cell specific markers CD90 and CD29 (Fig 1-D, E) and
negatively stained with hematopoietic lineage markers CD45 and
CD34 (Fig 1-F, G). Immunocytochemistric results revealed that
the hESSCs positively stained CD90 (Fig 1-H), but negatively
stained an epithelial specific marker cytokeratin (Fig 1-I).
These results showed that the P4, 6 hESSCs was characterized
by a homogenous cell population with depletion of hematopoietic
and epithelial cells.

Results
Morphology Observation of hESSC Culture
Three days after plating endometrial cells, a significant number
of cells attached to the tissue culture plates and grew to small
colonies (Fig1-A). Then, the small colonies gradually formed large
colonies at day 5–6 (Fig1-B) and finally achieved 90% confluence
at approximately day 8–10 (Fig1-C).

Immunocytochemistry Analysis of MKs Differentiated
from hESSCs
The P4–6 hESSCs were induced to differentiate into MKs in a
serum-free medium in the presence of thrombopoietin (TPO,
50 ng/ml). Generated MKs could be visualized under light
microscope (Fig 2-A). MK maturation involves the acquisition
of characteristic cell surface markers, such as glycoprotein (GP) IIb

Figure 1. Culture and identification of hESSCs. Representative images (106) of hESSC culture from endometrial stromal cells at different time
points: A, at day 3 (small colonies); B, at day 5 (large colonies); C, at day 10 (90% confluence). Representative flow cytometric plots of hESSCs at 4th
passage: D, CD90; E, CD29; F, CD45; G, CD34 (left curves: isotype controls; right curves: antibodies). Representative immunocytochemistry pictures
(206) of hESSCs at 4th passage: H, CD90; I, cytokeratin.
doi:10.1371/journal.pone.0044300.g001
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Sox2:0.5260.03 and 0.2060.02, control versus differentiation,
P,0.01, n = 4, Fig 4-A, B).

(CD41a), GPIba (CD42b). Immunofluorescence studies revealed
positive immunoreactivity in generated MKs for the MK specific
surface markers CD41a (Fig 2B1–B3) and CD42b (Fig 2C1–C3).
The generated MKs showed significantly increased expression
rates (CD41a: 160.5% and 3863%; CD42b: 0.960.4% and
2762.5%; control versus differentiation, P,0.01, n = 4, Fig 2-D)
after differentiation.

Differentiated MKs Release PLTs into Culture Medium
The differentiation medium was collected for examining the
PLTs released from MKs by flow cytometric analysis. The
diameter of normal PLTs is approximately 2–3 mm. The gate
was fixed in the forward scatter and side scatter histogram by using
of 2 mm and 4 mm calibration beads (Fig 5-A). Our data indicate a
population of cells presented within the gate and had an
expression rate of CD41a (160.4% and 9062%, control versus
differentiation, P,0.01, n = 4, Fig 5-B, C). These data demonstrate that PLTs were released from generated MKs. The
calculated number of PLTs produced was approximately
361056360 PLTs from 1.861056642 hESSCs. The level of
PLT in the differentitation medium supernatant was 1661
number/ml.

Flow Cytometric Analysis of MKs Differentiated from
hESSCs
Differentiated MKs were also detected by flow cytometric
analysis of CD41a and CD42b expression. Flow cytometric results
revealed that the expression rates of CD41a and CD42b were
significantly increased (CD41a: 160.09% and 3963%, Fig 3-A,
B; CD42b: 1.260.06% and 2862%, Fig 3-C, D; control versus
differentiation; P,0.01, n = 4) after differentiation. These data are
summarized in Fig 3-E. The calculated number of MKs produced
was approximately 5.561046500 MKs (CD41a+) from 1.861056
642 hESSCs.
In addition, MK differentiation was identified using DNA
ploidy study. We found that cells in the MK differentiation group
displayed polyploidy ranged from 2 N to 16 N (Fig 3-G), whereas,
the cells in control group were diploidy and the DNA ploidy was
2 N (Fig 3-F).

Generated PLTs Bind to Fibrinogen and Express CD62p
after Thrombin Stimulation
The function of the released PLTs was determined by thrombin
(5 U/ml, 10 min) stimulation in the presence of 488-labeled
fibrinogen. We found the fibrinogen binding rate was increased
(160.4% and 3263%, control versus thrombin, P,0.01, n = 4)
after thrombin stimulation (Fig 6-A, B). These data are
summarized in Fig 6-C. The function of the released PLTs was
also detected by the expression of P-selectin (CD62p) with
thrombin stimulation. And the results showed the CD62p
expression rate was up-regulated (2.561% and 2664%, control
versus thrombin, P,0.01, n = 4) after thrombin stimulation (Fig 6D, E). These data are summarized in Fig 6-F. Our data from
thrombin stimulation studies revealed that PLTs released from
hESSC-differentiated MKs were functional.

The Levels Oct4 and Sox2 Were Decreased after MK
Differentiation
The expression levels of the pluripotent transcription factors
(Oct4 and Sox2) in the cells of MK differentiation and control
groups were examined by western blot analysis. The expression
levels of both Oct4 and Sox2 were significantly reduced in cells in
the differentiation group (Oct4:0.3260.01 and 0.0860.01;

Figure 2. Microscopic analysis of MKs differentiated from hESSCs. MK differentiation can be observed by cell size under light microscope (A:
MKs, indicated by black arrows) and determined by immunocytochemistry staining (B1: CD41a; C1: CD42b; B2, C2: PI; B3, C3: merged. scale bar:
75 mm). D, summarized data showing the expression rates are expressed as mean 6 SEM, *P,0.01, control versus differentiation, n = 4/group.
doi:10.1371/journal.pone.0044300.g002
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Figure 3. Flow cytometric analysis of MKs differentiated from hESSCs. Flow cytometric analysis of MK differentiation rate was determined
by specific cell surface markers (A, B: CD41a; C, D: CD42b; left curves: isotype controls; right curves: antibodies). E, summarized data are expressed as
mean 6 SEM, *P,0.01, control versus differentiation, n = 4/group. Analysis of DNA polyploidy of the MKs differentiated from hESSCs (F, control; G, MK
differentiation).
doi:10.1371/journal.pone.0044300.g003

studies. Initially, Chan and coworkers [22,23] demonstrated the
presence of clonogenic stromal stem cells with high proliferative
potential in active cycling and inactive endometrium. And their
high proliferation rate was preserved despite their long duration in
culture (more than 20 months) [17]. These innate characteristics
suggest that hESSCs may have advantages over other adult stem/
progenitor cells and may represent a new resource for cell-based
therapies and regenerative medicine. Recent studies have been
shown that hESSCs are able to differentiate into multiple cell
lineages, including adipocytes, chondrocytes, osteoblasts, neurons
and pancreatic b-cells [17–21]. However, differentiation of
hESSCs into MKs has not been reported yet.
This study is the first time to describe a culture system in which
MKs was differentiated from hESSCs in a serum-free medium
supplemented with TPO. In this study, P4–6 hESSCs were used for
the differentiation experiment. These hESSCs was a homogenous
cell population as evidenced by highly positive expression of
stromal cell markers (CD29 and CD90), negative expression of
hematopoietic stem cell markers (CD34 and CD45) and an
epithelial marker cytokeratin. After 18 days differentiation, the
hESSCs-derived MKs displayed polyploidy with the DNA ploidy
ranged from 2 N to 16 N, accompanying with a significantly
increased expression profile of characteristic MK specific plasma
membrane glycoprotein markers (e.g., CD41a, CD42b). In
addition, since Oct4 and Sox2 are pluripotent human stem cell
markers detected in endometrium and other adult stem cells [24–
26], we also verified the differentiation of hESSCs by measuring
the expression profile of Oct4 and Sox2. Our data indicated that

PLTs Released from Differentiated MKs Share Similar
Ultra-structural Characteristics with Peripheral Blood
Derived PLTs
The morphology and ultra-structural composition of PLTs
released from generated MKs was examined by transmission
electron microscopy. A representative image of a generated PLT,
shown in Fig 7-A, displayed a discoid shape and was similar to the
discoid shape characteristic of peripheral blood PLTs (Fig 7-B).
Magnified views show the presence of alpha granules, vacuoles
and dense tubular system in PLTs released from differentiated
MKs (Fig 7-C). These intracellular structures are similar to PLTs
harvested from human peripheral blood (Fig 7-D).

Discussion
In this study, we developed a protocol to effectively induce the
differentiation of hESSCs into MKs. Generated MKs were able to
release functional PLTs with size and ultra-structure characteristics similar to normal PLTs obtained from peripheral blood.
Combined methodologies such as immunocytochemistry, flow
cytometry and transmission electron microscopy were applied to
characterize the generated MKs or PLTs.
Human endometrium is characterized by its cyclic selfregeneration during the course of menstrual cycle in reproductive-age females. The upper functionalis layer (0.5–1 mm to 5–
7 mm thickness), which sheds at menstruation is thought to
regenerate from stem cells in the basalis layer of endometrium.
The existence of hESSCs has been investigated in several previous
PLOS ONE | www.plosone.org
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hESSCs and that the generated MKs can release functional PLTs.
PLTs generated in such an approach could be applied to
autologous PLT transfusion. Our future work is to examine
whether hESSCs induced inducible pluripotent stem cells (iPSCs)
could further increase the efficiency of MK differentiation and
PLT production.

Conclusion
In conclusion, the results of our study demonstrate that hESSCs
can differentiate into MKs which subsequently release functional
PLTs in an in vitro culture system. The hESSCs have the potential
to serve as a new source of PLT production for clinical application.

Materials and Methods
Ethics Statement
For this study, ethics approval was obtained from the
Institutional Review Boards and Research Committees at the
Miami Valley Hospital and Wright State University. Written
informed consent was obtained from each patient and the patient
confidentiality was protected according to HIPPA guidelines.

Human Endometrial Tissue Samples
Four premenopausal women (30–45 years old) who were
undergoing hysterectomy for benign disease indications, leiomyoma, were selected. The full thickness endometrium attached to
myometrium sample was collected and put into PBS containing
10% FBS and 2% antibiotic-antimycotic solution (final concentration: 200 mg/ml penicillin G sodium and 200 mg/ml streptomycin sulfate) (Invitrogen, Carlsbad, CA). The sample was
processed within 30–60 min.

Figure 4. Cellular Oct4 and Sox2 expression after MK
differentiation from hESSCs. The expression levels of Oct4 and
Sox2 in cells were decreased after induction of MK differentiation (A:
representative western blot bands; B: summarized data). Data are
expressed as mean 6 SEM, *p,0.01, control versus differentiation,
n = 4/group.
doi:10.1371/journal.pone.0044300.g004

Isolation and Culture of hESSCs

the expression levels of Oct4 and Sox2 were both significantly
reduced after differentiation, indicating their phenotype paralleled
the molecular changes associated with differentiation.
In order to further explore whether the differentiated MKs were
able to release PLTs, MK differentiation medium were collected to
detect PLT production by analysis of specific marker CD41a and
size (2–4 mm). Our data showed that the level of released PLTs in
the culture medium was around 16 number/ml. Moreover, we
functionally evaluated the produced PLTs with two thrombin
stimulation studies. One is thrombin stimulation induced activation of fibrinogen receptor (aIIbIIIa), which is an integrin complex
found on PLTs and aids in PLT activation by conformational
change. The result showed the fibrinogen binding rate significantly
increased from 160.4% to 3263% with the stimulation. The
other is thrombin stimulation induced surface expression of
antigen P-selectin (CD62p). The result showed the percentage of
specific CD62P+ PLTs significantly increased from 2.561% to
2664% with the stimulation. Both stimulation studies demonstrate
that the released PLTs from generated MKs are functional in our
culture system. In addition, we applied transmission electron
microscopy (TEM) to examine the ultra-structures of generated
PLTs. The TEM examination results revealed that the produced
PLTs displayed a discoid shape and contained a normal
distribution of organelles such as alpha granules, vacuoles and
dense tubular system, which are indistinguishable from the PLTs
obtained from peripheral blood. These data are consistent with
previous studies on in vitro generated MKs and PLTs from other
tissue of origin sources [9,12,27–29]. Despite further studies are
required to determine the optimal protocols for MK differentiation
from hESSCs, as well as for PLT release from MKs, this study for
the first time reports that MKs can be feasibly generated from
PLOS ONE | www.plosone.org

As soon as the sample was delivered to the laboratory, the
endometrial tissue was mechanically and enzymatically digested
into a single-cell suspension as previously reported with slight
modifications [17,22]. Briefly, the endometrium layer was
dissected, minced into 1–2 mm3 pieces, and digested in enzyme
digestion buffer, PBS with 25 mM HEPEs (Invitrogen, Carlsbad,
CA), 1 mg/ml collagenase (Roche Applied Science, Indianapolis, IN), 0.1 mg/ml DNAse1(Sigma, Fairfax, VA) and 1%
antibiotic-antimycotic solution, in a humidified 5% CO2/95%
air atmosphere at 37uC for 45 min with a brief shaking once
every 5 min. The cell suspension was filtered through a 70 mm
wire sieve to remove mucus and undigested tissue. The filtrates
were centrifuged at 400 6 g for 10 min to collect cells. Cell
pellets were resuspended with hESSCs culture medium,
DMEM/F12 (Invitrogen, Carlsbad, CA) supplemented with
10% FBS and 1% antibiotic-antimycotic solution. The cells
were seeded in a 6-well tissue culture plate in a humidified 5%
CO2/95% air incubator. The medium was changed twice a
week during expansion of the cells. When the cells were 90%
confluent, they were detached using 0.025% trypsin/0.01%
EDTA and passaged at a ratio of 1:3.

Identification of hESSCs
Passage 4–6 endometrial stromal cells were used for identifying
hESSCs by immunocytochemistry and flow cytometry analyses.
For immunostaining, the cultured cells on coverslips were fixed
with 2% PFA solution and stained with monoclonal antibodies
mouse anti-human CD90 (Thy-1, 1:25) (BD Biosciences, San Jose,
CA) and mouse anti-human cytokeratin (1:50, Dako, Carpinteria,
CA) followed by a Cy3-conjugated donkey anti-mouse IgG second
antibody (1:250, Jackson lmmunoResearch Lab, West Grove, PA).
5
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Figure 5. Analysis of PLT production from hESSC-differentiated MKs. Representative flow cytometric plots show the location of PLT
population (A, oval indicates the PLT population; circle and square indicate respective locations of 2 mm and 4 mm calibration beads) and the
percentage of CD41a expression of the cells gated on P1 (B: control, C: differentiation; left curves: isotype controls; right curves: antibodies). D,
summarized data of MK and PLT yield per input of hESSC. Data are expressed as mean 6 SEM, *p,0.01, control versus differentiation, n = 4/group.
doi:10.1371/journal.pone.0044300.g005

Fairfax, VA), 2 mM L-glutamine (Invitrogen, Carlsbad, CA),
4 mg/ml LDL cholesterol (Sigma, Fairfax, VA), 50 mM 2-bmercaptoethanol (Sigma, Fairfax, VA), 20 mM each nucleotide
(Sigma, Fairfax, VA), 20 mM dNTP (Invitrogen, Carlsbad, CA),
and 1% antibiotic-antimyotic solution for 18 days. Half of the
culture medium was replaced in the first 9 days. The culture
medium (2 ml) from day 10–18 was collected for PLT isolation.
Cells on culture plates were harvested for flow cytometry or
western blotting analysis. Cells on coverslips were used for MK
immunocytochemistry assay.

Then the cells were mounted with fluorescence mounting medium
and imaged under a fluorescence microscope (Leica TCS SP2,
Leica, Germany).
For flow cytometry, the cultured cells were trypsinized and
centrifuged. Cell pellets were resuspended and incubated with PEor FITC-conjugated antibodies in a final volume of 100 ml for
30 min at 4uC in the dark, individually. Isotype matched (IgG)
non-specific antibodies served as negative controls. Antibodies
(PE-conjugated anti-human CD29, PE-conjugated anti-human
CD90, FITC-conjugated anti-human CD45, FITC-conjugated
anti-human CD34, FITC-conjugated mouse IgG1 isotype control,
PE-conjugated mouse IgG1 isotype control) were purchased from
eBioscience (San Diego, CA). The concentrations of antibodies
were applied according to manufacture instructions. A total of at
least 10 000 events were collected and analyzed using Accuri C6
flow cytometer and CFlow Plus Analysis software (Ann Arbor,
MI).

Characterization of MK Differentiation by
Immunocytochemistry Assay
MK differentiation was determined by analysis of surface
specific markers (CD41a and CD42b). For immunostaining, the
cultured cells on coverslips were fixed with 2% PFA solution for
30 min at RT, and permeabilized with 0.3% triton X-100 for
another 30 min. Then slides were incubated overnight with prediluted primary antibody CD41a (glycoprotein aIIb) or CD42b
(glycoprotein aIb, both from eBioscience, San Diego, CA), and
FITC-conjugated anti-mouse IgG secondary antibody (1:100,
Jackson lmmunoResearch Lab, West Grove, PA) for 2 hrs. Cell
nuclei were stained with propidium iodide (PI) solution
containing RNAse (PI/RNAse final concentration: 20 mg/ml,
Sigma, Fairfax, VA) for 15 min in the dark. Between each step,
slides were washed with PBS/0.1% BSA. Cells were examined

Differentiation of MKs from hESSCs
The P4–6 of hESSCs were plated as 1.86105 cells/well on 6-well
tissue culture plates or coverslipes. The cells were cultured in
Iscove’s modified dulbecco’s medium (IMDM, Invitrogen, Carlsbad, CA) supplemented with 50 ng/ml TPO (BD Biosciences, San
Jose, CA) in differentiation group or without TPO in control
group, 0.5% BSA (Sigma, Fairfax, VA), 200 mg/ml iron saturated
transferring (Invitrogen, Carlsbad, CA), 10 mg/ml insulin (Sigma,
PLOS ONE | www.plosone.org
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Figure 6. Functional assay of PLTs released from generated MKs. Thrombin stimulation raised fibrinogen binding and CD62p expression in
PLTs released from the generated MKs. Representative flow cytometric plots (A, B: fibrinogen binding; D, E: CD62p. left curves, isotype controls; right
curves, antibodies). Summarized data show fibrinogen binding (C) and CD62p expression (F) in PLTs after thrombin stimulation. Data are expressed as
mean 6 SEM, *P,0.01, control versus stimulation, n = 4/group.
doi:10.1371/journal.pone.0044300.g006

by confocal fluorescence microscopy (Leica TCS SP2, Leica,
Germany). To assess the differentiation rate, the numbers of
CD41a or CD42b positive staining cells in 5 individual fields
were accounted and averaged.

Characterization of MK Differentiation by Western Blot
Analysis of Oct4 and Sox2 Expression
After hESSCs were cultured in MK differentiation or control
medium for 18 days, cells were harvested with lysis buffer. Cell
lysates were then centrifuged at 10 000 6 g for 5 min. Protein
concentrations in the supernatants were determined by the
Bradford method using Bio Rad reagent (Bio Rad Laboratories)
and the same amount of protein (30 mg) from each was separated
by 10% Tris-Glycine SDS-Page gel (Bio Rad Laboratories) and
transferred to PVDF membrane. After blocking with 5% non-fat
milk for 1 hr at RT, membranes were incubated for primary
monoclonal antibodies rabbit anti-Oct4 (1:500, Abcam Inc,
Cambridge, MA) and mouse anti-Sox2 (1:2000, R&D systems,
Minneapolis, MN) overnight at 4uC, respectively. After 3 times
wash, secondary antibodies horse raddish peroxidase (HRP)
conjugated goat anti rabbit (1:4000) and HRP-conjugated donkey
anti mouse (1:4000, both were from Jackson lmmunoResearch
Lab, West Grove, PA) were probed, individually. Then the signal
was read with a luminescent analyzer (LAS-3000, Fujifilm, Japan)
and the band intensities were analyzed by ImageGauge (Fujifilm,
Japan).

Characterization of MK Differentiation by Flow Cytometry
Surface specific markers (CD41a and CD42b) were also used for
flow cytometric analysis of MK differentiation. The cells were
detached, centrifuged and fixed with 2% PFA. Then, the cells
were permeabilized with blocking buffer containing 0.3% triton
X-100, incubated with FITC-conjugated antibodies in a final
volume of 100 ml for 30 min at 4uC in the dark, respectively.
Antibodies (FITC-conjugated anti-CD41a, FITC-conjugated antiCD42b, FITC-conjugated mouse IgG1 isotype controls) were
purchased from BD Biosciences (San Jose, CA). The concentrations of antibodies were applied according to manufacture
instructions. Cell nuclei were stained with PI solution containing
RNAse (PI/RNAse final concentration: 20 mg/ml) for 30 min in
the dark. A total of at least 150 000 events were collected and
analyzed using an Accuri C6 flow cytometer and CFlow Plus
Analysis software (Ann Arbor, MI).

PLOS ONE | www.plosone.org
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Figure 7. Ultra-structural analysis of released PLTs. Electron micrographs show that generated PLTs have typical ultra-structural morphology
and cellular organelles (alpha granules, vacuoles and dense tubular system) as PLTs from peripheral blood. A: generated PLT; B: blood PLT; C:
magnified view from A; D: magnified view from B; G: alpha granule; V: vacuole; DTS: dense tubular system. Scale bars: 0.5 mm in A and B.
doi:10.1371/journal.pone.0044300.g007

Flow Cytometric Analysis of PLT Production in Culture
Medium

Functional Analysis of Released PLTs
The functional capabilities of generated PLTs were analyzed for
both fibrinogen binding and surface antigen CD62P expression in
the presence or absence of thrombin stimulation. To prepare cell
samples, PLTs were harvested from the culture medium,
centrifuged at 150 6 g for 20 min to remove large cells,
resuspended and then centrifuged at 1700 6 g for 30 min to
sediment a PLT pellet as above described. The PLT pellets were
resuspended in modified Tyrode-HEPEs buffer (138 mM NaCl,
0.36 mM NaH2PO4, 2.9 mM KCl, 12 mM NaHCO3, 10 mM
HEPEs, 5 mM glucose, 1 mM MgCl2, and 1 mM CaCl2,
pH 7.4).
To determine fibrinogen binding, generated PLTs were
stimulated with agonist thrombin (5 U/ml, Sigma, Fairfax, VA)
for 10 min at 37uC in the presence of Alexa Fluor 488-labeled
human fibrinogen (100 mg/ml, Invitrogen, Carlsbad, CA) or the
isotype control mouse IgG. For controls, generated PLTs without
thrombin stimulation were also stained with Alexa Fluor 488labeled fibrinogen or its corresponding isotype control IgG.
To determine the surface expression of P-selectin (CD62p,
eBioscience, San Diego, CA), after thrombin stimulation, the
generated PLTs were fixed with 2% PFA and incubated with
FITC-conjugated anti-CD62p or the isotype control mouse IgG.
For controls, generated PLTs without thrombin stimulation were
also stained with FITC-conjugated anti-CD62p or its corresponding isotype control IgG. Final volume per tube was brought to
100 ml. A total of at least 100 000 events were collected each and
all samples were analyzed by Accuri C6 flow cytometer. All

To determine the number of PLT released, we collected the
culture medium (2ml) of the same well of a 6-well culture plate
every day from day 10–18 of the differentiation group or control
group. The collected culture medium was centrifuged at 150 6 g
for 20 min to eliminate any large cells each time. The supernatant
was fixed with 2% PFA, centrifuged at 1700 6 g for 30 min to
sediment a PLT pellet. The pellet was resuspended with PBS/1%
FBS, and stored at 4uC for further analysis. For analysis, the fixed
and stored PLT pellets from the same well were pooled together
and then divided into two groups. One group was resuspended
and incubated with FITC-conjugated anti-CD41a antibody in a
final volume of 100 ml for 30 min at 4uC in the dark. The other
group was incubated with Isotype matched (IgG) non-specific
antibody in the same amount of volume (100 ml) and served as
negative control. 2 mm and 4 mm flow cytometry calibration bead
solution was added into each tube. The concentrations of
calibration beads and antibodies were applied according to
manufacture instructions. A total of at least 10 000 events within
the gate were collected and analyzed using the Accuri C6 flow
cytometer. The concentration of PLT (CD41a+) in the culture
medium supernatant of each well was calculated as: PLT
numbers/ml of culture medium = [CD41a+ numbers 6 100 ml/
actual run volume (ml)]/total culture medium volume (2 6 9 6
103 ml) 6 groups (2).
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antibody application concentrations followed manufacture instructions.

specimen were then stained with lead citrate (Fisher Scientific,
Pittsburgh, PA) for 10 min, rinsed with double distilled water
another 5 times and allowed to air dry. Finally, all specimens were
examined with an EM 208 (Philips) transmission electron
microscope at an accelerating voltage of 70 KV.

Ultra-structure Analysis of Generated PLTs
PLT specimens for ultra-structural study by TEM were
prepared as described previously with slight modifications [9,30].
Briefly, generated PLTs in culture medium supernatant were
collected as above described. Peripheral blood samples were
collected from the health donors using standard phlebotomy
techniques into a collection tube containing acid-citrated-dextrose
(ACD) solution. The blood samples were centrifuged at 150 6 g
for 20 min to obtain PLT-rich plasma (PRP). Blood PLTs were
fixed in 2% glutaraldehyde in 0.1 M phosphate buffer for 1 hr at
4uC. The samples were then washed, post-fixed with 1% osmium
tetroxide (Electron Microscopy Science, Hatfield, PA) in 0.1 M
phosphate buffer for 2 hrs at 4uC, dehydrated with a graded
ethanol series and propylene oxide (Sigma, Fairfax, VA), and
embedded in spurr resin 812 (Sigma, Fairfax, VA) and baked.
Ultrathin sections (60–80 nm) were prepared with MT700,
mounted on 300-mesh copper grids, stained with 2% uranyl
acetate (Fisher Scientific, Pittsburgh, PA) for 5 min, rinsed with
double distilled water for 5 times, and allowed to dry. The

Statistic Analysis
Results were described as mean 6 SEM. The p value ,0.05
was considered to be statistically significant in the paired t-test.
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